Over the past 10 years, Vivek Garipalli has been one of our country’s most impactful (though largely quiet) supporters of health tech innovation, bettering countless lives across a myriad of circumstances. For example, his ventures have improved cancer treatment and accelerated oncology research, improved early detection of chronic kidney disease, established primary care clinics across the neediest communities with complex needs, and spurred access to health insurance coverage across the African continent.
Vivek Garipalli is dedicated to improving healthcare for all and is recognised as a leading entrepreneur and business expert in the field. He has spent most of his career building innovative healthcare businesses that have improved the service patients receive in the US. Vivek created an impressive five health care companies before the age of 40. He has used this wealth of experience in the industry to co-found Clover Health, a disruptive company that aims to change the healthcare system for the better.
When Vivek Garipalli founded Clover Health, he identified the significant misalignment within the industry between healthcare providers and insurance companies. Vivek wanted to reduce doctor-insurer friction whilst increasing the visibility into the health of each patient. He saw that this would improve the service patients receive whilst making it more accessible. Little had been done for the uninsured and underinsured patient groups, and Vivek has set about changing the system.
Prior to founding Clover Health, Vivek Garipalli co-founded CarePoint Health, an integrated healthcare system in New Jersey whose mission is to serve uninsured and underinsured patient populations. As with Clover Health, Vivek’s aim was to readjust healthcare’s focus back to the patient, rather than financial results.
In 2014, Vivek Garipalli also co-founded a healthcare services revenue cycle company called Ensemble Health before teaming up with a couple of friends at Flatiron Health, where held an active position on the board, helping to drive business strategy and development which led to a successful sale to Roche in 2018.
Vivek’s experience also branches into health tech, having served as a board member on both Doctor Evidence and Medically Home – two technology firms that support innovation within the healthcare industry.
Wormhole Capital, the investment arm of Vivek Garipalli’s family office, partners with special founders who have the rare ability to anticipate what will move society and culture forward and the aptitude to build a transformative, category-defining company, from the outset through to massive scale. While sector-agnostic, Wormhole focuses on a company’s lasting impact and invests at any stage from inception to growth rounds.
Vivek Garipalli started his journey in business at the University of Emory, where he studied business administration with a focus on entrepreneurship. On top of his successful career, Vivek has supported several charities, including The Bowery Mission, a charity that tackles homelessness in New York.